Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Titel:
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Auteur:
Sortais, Clara Lok, Anne Tessoulin, Benoit Gastinne, Thomas Mahé, Béatrice Dubruille, Viviane Blin, Nicolas Touzeau, Cyrille Moreau, Anne Bossard, Céline Peterlin, Pierre Garnier, Alice Guillaume, Thierry Le Bourgeois, Amandine Chevallier, Patrice Moreau, Philippe Leux, Christophe Le Gouill, Steven